Biogen Inc (OQ:BIIB)

Business Focus: Biopharmaceuticals

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for BIIB within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 29th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 12/20 Mar 11/20 Sherwin Stephen A Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -1,355  
Mar 12/20 Mar 11/20 Sherwin Stephen A Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -10,923  
Mar 12/20 Mar 11/20 Sherwin Stephen A Direct Ownership Common Stock S - Open market or private sale -270 $295.29
Mar 12/20 Mar 11/20 Sherwin Stephen A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 1,355 $58.46
Mar 12/20 Mar 11/20 Sherwin Stephen A Direct Ownership Common Stock S - Open market or private sale -2,164 $295.22
Mar 12/20 Mar 11/20 Sherwin Stephen A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,923 $58.46
Feb 19/20 Feb 15/20 Vounatsos Michel Direct Ownership Restricted Stock Unit J - Other transaction -3,657  
Feb 19/20 Feb 15/20 Vounatsos Michel Direct Ownership Restricted Stock Unit M - Exercise or conversion exempt under rule 16b-3 -4,847  
Feb 19/20 Feb 15/20 Vounatsos Michel Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -2,150 $333.00
Feb 19/20 Feb 15/20 Vounatsos Michel Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,847  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for BIIB within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 29th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 12/20 Mar 11/20 Sherwin Stephen A Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -1,355  
Mar 12/20 Mar 11/20 Sherwin Stephen A Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -10,923  
Mar 12/20 Mar 11/20 Sherwin Stephen A Direct Ownership Common Stock S - Open market or private sale -270 $295.29
Mar 12/20 Mar 11/20 Sherwin Stephen A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 1,355 $58.46
Mar 12/20 Mar 11/20 Sherwin Stephen A Direct Ownership Common Stock S - Open market or private sale -2,164 $295.22
Mar 12/20 Mar 11/20 Sherwin Stephen A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 10,923 $58.46
Feb 19/20 Feb 15/20 Vounatsos Michel Direct Ownership Restricted Stock Unit J - Other transaction -3,657  
Feb 19/20 Feb 15/20 Vounatsos Michel Direct Ownership Restricted Stock Unit M - Exercise or conversion exempt under rule 16b-3 -4,847  
Feb 19/20 Feb 15/20 Vounatsos Michel Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -2,150 $333.00
Feb 19/20 Feb 15/20 Vounatsos Michel Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,847  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $BIIB

Competitors

Competitors with Recent Insider Filings
Allakos (OQ:ALLK)
ChemoCentryx (OQ:CCXI)
BioMarin Pharmaceutical (OQ:BMRN)